Prevalence of gastrointestinal parasites in Faisalabad and comparative efficacy of Ivermectin and Albendazole

Abstract

Current study was conducted to evaluate the prevalence rate of gastrointestinal tract (GIT) parasites of cats in Faisalabad and check the comparative efficacy of Ivermectin and Albendazole. A total of 384 fecal samples of cats were collected randomly from different government and private clinics of district Faislabad. Ivermectin and Albendazole were used for the treatment against the GIT parasites. After clinical examination, 70 positive cats with GIT parasites were grouped as follows: group A (n=30) which was treated with graded doses of ivermectin (merial), similarly group B (n=30) treated with graded doses of albendazole (zental) and group C (n=10) kept as a control. Fecal samples were processed in postgraduate laboratory, Department of Clinical Medicine and Surgery, University of Agriculture, Faisalabad. Quantitative fecal examination was performed to observe the egg per gram of feces before and after treatment. The percentage of infection was found higher in female cats 33.33% than male 24.44%. The prevalence in adults and kittens was recorded as 24.10% and 42.45% respectively. T. cati was found more prevalent with the infection rate of 7.03% followed by T. leonina, A. duodenalis, A. abstrus, T.Taeniaformimus, D. caninum, A. tubaeforme and T. gondii with the infection rate of 5.4, 4.1, 3.7, 2.6, 2.3, 2.3 and 1.8% respectively. Comparatively ivermectin showed more significant results against GIT parasites of cats than albendazole.

Efficacy of Closantel, Ferula Asafetida and Common Dewormer Against Haemoncus Contortus in Small Ruminants

“…Field populations of H. contortus species show resistance to major classes of anthelmintic like benzimidazole, macrocyclic lactons and imidazothiazoles. In Pakistancommonly used anthelmicts are albenzaloes and ivermectin, and anthelmintic resistance is the main challenge to treat Haemonchosis in animals (Iqbal et al 2017, Kotze and Prichard 2016, Shalaby 2013.…”